Michael Slade, MD, MSCI

Michael Slade, MD, MSCI

Bone Marrow Transplant Specialist, Oncology

Primary Academic Title

Assistant Professor of Medicine, Clinical Oncology, Washington University School of Medicine

Clinical Expertise

Multiple myeloma and cellular therapies, including bone marrow transplant and CAR T cell therapy

Research Interest

Dr. Slade's current research is focused on cellular immunotherapy and plasma cell dyscrasias, including multiple myeloma and its precursor states. His laboratory-based research is focused on understanding mechanisms of chimeric antigen receptor (CAR) T cell failure in patients with multiple myeloma, including tumor evolution, modulation of the immune microenvironment and CAR T cell exhaustion. His clinical research is focused on the role of autologous stem cell transplant in multiple myeloma and on advanced methods of disease monitoring following myeloma treatment, including ultra- sensitive next generation sequencing, flow cytometry and mass spectrometry.

Education

  • 2017: MD, Washington University School of Medicine, St. Louis, MO
  • 2017: MSCI, Washington University School of Medicine, St. Louis, MO

Training

  • 2017 - 2020: Internal Medicine Resident , Washington University/Barnes-Jewish Hospital, St. Louis, MO
  • 2020 - 2023: Hematology/Oncology Fellow (Chief Fellow), Washington University/Barnes-Jewish Hospital, St. Louis, MO

Board Certification

  • 2020: American Board of Internal Medicine, General
  • 2022: American Board of Internal Medicine, Oncology

Contact Information

  • Washington University Medical Campus

    4921 Parkview Place
    Saint Louis, MO 63110

  • North St. Louis County

    1255 Graham Road
    Florissant, MO 63031

Request an appointment